Erythropoietin in polycystic kidneys

Area of Science:

• Nephrology
• Endocrinology
• Molecular Biology

Background:

• Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by numerous renal cysts.
• Anemia is a common complication in end-stage renal disease, often linked to reduced erythropoietin (EPO) production by the kidneys.

Purpose of the Study:

• To investigate the source and characteristics of erythropoietin (EPO) production within renal cysts in patients with ADPKD.
• To determine if EPO production in ADPKD cysts is associated with specific cyst fluid conditions or cell types.

Main Methods:

• Analysis of serum EPO and hemoglobin levels in ADPKD patients with varying renal function.
• Measurement of bioactive EPO concentrations in cyst fluid aspirated from 357 renal cysts.
• In situ hybridization using a cDNA probe for human EPO to localize EPO mRNA in cyst wall tissues.

Main Results:

• Variable concentrations of bioactive EPO were detected in ADPKD cyst fluid, with enrichment in cysts showing high sodium levels.
• EPO levels in cysts did not correlate with protein concentration or oxygen pressure.
• EPO mRNA was localized to stromal cells in the cyst walls, adjacent to proximal tubular malformations.

Conclusions:

• Interstitial cells near proximal tubular cysts in ADPKD kidneys can produce EPO.
• This localized EPO production may contribute to ameliorating anemia in end-stage ADPKD, independent of intraluminal oxygen levels.